YOLFTbeta
65

Perfect Medical Industry Co., Ltd.

6543 · TWO · Healthcare / Medical Instruments & Supplies

17.05TWD+0.05 (+0.29%)

Price History

Full chart

Market Stats

Previous Close17.00
Open17.00
Day Range16.25 – 17.05
52-Week Range16.90 – 29.29
Volume9.16K
Market Cap1.13B
P/E (TTM)30.08
Forward P/E0.00
EPS0.59
Dividend Yield1.92%
Beta0.07
50-Day Avg17.91
200-Day Avg21.55

About

Perfect Medical Industry Co., Ltd., together with its subsidiaries, engages in the manufacturing, processing, and trading of medical devices in Taiwan, Singapore, Malaysia, the United States, Vietnam, and internationally. The company offers hemodialysis blood tubing set; A.V. fistula needle set, needleless huber needle set/huber needle set; needleless transfusion set/transfusion set; needleless extension set; disposable syringe; and IV lock. It is also involved in wholesale and retail trading of medical consumables. The company was founded in 1989 and is headquartered in Changhua, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Kuo-Chi Hsu
  • HeadquartersNo.100, Xingong 1st Road, Changhua, Taiwan, 521051, Taiwan
  • Websitehttps://www.perfectmedical.com.tw

Leadership

  • Mr. Kuo-Chi HsuRepresentative Chairman & CEO
  • Ms. Ya-Tung YeCFO & Accounting Supervisor
  • Mr. Tung-Shun ChenAssistant Manager of Legal and Regulation Department and Quality Assurance Department
  • Mr. Shun-Jie XuDeputy General Manager of Management & Sustainable Operations
  • Mr. Hung-Jen ChenGeneral Manager

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue675.71M807.76M724.61M677.04M734.13M744.16M779.01M
Growth (%)-+19.54%-10.29%-6.57%+8.43%+1.37%+4.68%
Cost of Revenue523.06M555.03M515.08M542.63M533.58M505.96M578.25M
Gross Profit152.65M252.73M209.53M134.41M200.56M238.19M200.76M
Gross Margin22.59%31.29%28.92%19.85%27.32%32.01%25.77%
Operating Expense102.24M123.02M151.03M130.75M142.19M146.87M149.44M
Operating Income50.41M129.71M58.50M3.65M58.37M91.33M51.33M
Operating Margin7.46%16.06%8.07%0.54%7.95%12.27%6.59%
EBITDA82.10M175.75M114.14M78.23M115.48M167.37M145.81M
EBITDA Margin12.15%21.76%15.75%11.56%15.73%22.49%18.72%
Net Income36.44M100.69M38.77M14.27M40.09M89.12M54.25M
Net Income Margin5.39%12.47%5.35%2.11%5.46%11.98%6.96%
R&D5.15M7.57M5.58M7.12M7.40M9.30M15.83M
R&D as % of Total Revenue0.76%0.94%0.77%1.05%1.01%1.25%2.03%
Interest Expense1.13M2.05M2.96M4.46M4.37M3.72M6.83M
Interest Expense % of Total Revenue0.17%0.25%0.41%0.66%0.60%0.50%0.88%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets679.01M939.48M1.04B957.08M988.48M1.11B1.34B
Total Liabilities10.48M359.67M458.42M307.46M324.72M310.89M520.95M
Total Equity517.12M579.81M578.02M649.62M663.76M803.86M823.08M
Cash68.28M94.88M119.25M92.74M161.41M207.18M265.39M
Total Debt62.01M204.16M319.98M208.32M211.96M184.77M-
Net Debt-6.28M109.28M200.74M115.58M50.55M-22.41M79.47M

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow95.97M118.19M4.44M105.61M149.87M143.54M107.62M
Investing Cash Flow-129.32M-189.59M-61.84M-44.39M-63.57M-110.92M-
Financing Cash Flow68.44M101.42M81.77M-85.53M-16.40M13.47M-
Capital Expenditure49.17M144.46M103.57M52.75M66.31M99.24M198.94M
Free Cash Flow46.80M-26.27M-99.13M52.87M83.56M44.30M-91.32M
Dividends Paid27.43M27.43M58.77M14.43M16.89M65.14M45.82M
FCF to OCF48.76%-22.22%-2231.13%50.06%55.76%30.87%-84.85%
Dividend Paid to FCF58.61%-104.41%-59.29%27.29%20.22%147.03%-50.17%

Key Statistics & Ratios

Market Cap1.13B
Enterprise Value1.34B
Trailing P/E30.08
Forward P/E0.00
Price / Sales1.27
Price / Book1.34
EPS0.59
Book Value14.87
Revenue (TTM)886.30M
Gross Profit (TTM)195.66M
EBITDA113.42M
Profit Margin4.01%
Operating Margin3.12%
Return on Equity4.42%
Return on Assets1.56%
Shares Outstanding63.53M
Shares Float33.17M
Beta0.07
Dividend Yield1.92%
Dividend Rate0.34
Payout Ratio32.36%

Dividends

20262×
0.15Sep 2, 20260.19May 6, 2026
20251×
0.83Apr 23, 2025
20242×
0.60Oct 9, 20240.58Jul 16, 2024
20231×
0.35Jul 4, 2023
20221×
0.31Aug 24, 2022
20211×
1.35Jun 30, 2021
20201×
0.63Jul 14, 2020
20191×
6.30Jun 4, 2019

Stock Splits

  • Aug 13, 20261027.09:1000
  • Aug 24, 20221032886.2:1000000